Remediation
MDR, QMSR and how things are in real life
Market Assessment │ Relationship & Project Management │ Interim Management │ Regulatory Affairs
für B2B-Unternehmen und Gesundheitseinrichtungen
Blog Post
Remediation
MDR, QMSR and how things are in real life
Blogbeitrag
- Michael Wartbüchler
- One Comment
für B2B-Unternehmen und Gesundheitseinrichtungen
Many remediation projects in the medical device industry do not fail because of a lack of effort.
They fail because of the wrong mental model – and a lack of perspective.
In many companies, remediation is still treated as a pure documentation exercise.
So companies start to
- rewrite documentation
- add more documentation
- migrate documentation
- digitize documentation
The result?
More documents, more systems, more complexity.
And in the end?
Often the same problems as before.
Often even more questions and uncertainty than before.
That is exactly the point:
Under MDR – and now with the new FDA QMSR – it is no longer enough that documents simply exist. What matters is whether the system is logically connected, effective, and works in everyday practice.
Many companies still think in terms of paper and binders, not in data points and logical relationships.
What we often see in practice:
- Risk management, CER, PMS, and CAPA are formally in place, but not properly linked.
- The QMS has evolved historically, but it was never designed as a system. It is treated as something separate — and no one really understands it.
- An eQMS was implemented, but it merely digitized the existing chaos
- After mergers and acquisitions, systems were simply added, instead of being integrated.
Responsibilities are unclear, authority is not defined, and neither roles nor functions are clearly described.
Decisions are not data-driven. This is not an effective QMS. And it will not become an effective QMS just because the Notified Body does not find many issues during audits.
That is not confirmation.
It is fragmentation with audit risk.
And above all:
It has significant economic consequences.
Because a weak QMS does not just cost audit points, rework, or lead to critical questions with high effort:
- It consumes time
- It costs money
- It reduces efficiency
- It erodes trust
It costs employee motivation and loyalty.
And in the worst case, it costs market share, innovation, and overall performance.
That is why remediation is not just a documentation exercise for compliance.
Remediation is a governance and business model issue. It must be driven top-down.
Based on project experience, what works is usually surprisingly clear:
- First standardize processes, then select tools
- End-to-end process thinking instead of functional silos
- Product family approach instead of a document graveyard
- Integration of logical interfaces, including service
- Governance instead of individual initiatives
- Focus on effectiveness, not just formal compliance
Many companies are digitizing and losing money every day before they realize:
Doing the right things at the right time.
That is our approach for your success.
Is your QMS driving your business — or slowing it down in everyday operations?
I look forward to your thoughts in the comments or to speaking with you personally.
You’ll find the link to schedule a meeting in the first comment.
#MDR #QMSR #QualityManagement #Remediation #eQMS #FDA #MedTech #CAPA #OperationalExcellence
- Michael Wartbüchler
- One Comment
One Response
https://medtech-partner.com/en/meeting-planner/